Post by
TheLandedEagles on Apr 27, 2024 9:10pm
High Impact...multi-bagger!!!!
Investors looking for Big Rewards with minimal risk at this late stage of a FDA imminent approval,...needs to have a locked-in share position in PharmaTher....Hugh upside very soon.
Look to the company's latest February 2024 Presentation on their web-site. Hold and Accumulate, at these extremely low prices....All time high was $1.20/share in 2021, raised $10mm in August 2021 at .66 cents/share with warrants expiring in 2026 at .80 cents exercise price, and that will bring in more than $6mm in cash and adding in their current $4mm cash, gives them a total of $10mm to finance its marketing/Sales and distribution for its approved FDA KETRAX....NO NEED FOR ANY FINANCING!!! Preventing share dilution....great financial position ...
Comment by
Itistoo on Apr 29, 2024 12:56am
They are actually closer to 2 mil in the bank right now, so they really need to get this approval sooner than later. Just as important as that they need to have clients and sales lined up. If they can line those ducks up and get a nice bump in SP to execute warrants, that would be ideal. If not, cash burn will get to them and they will have to do a raise.